Parvovirus B19 infections in adults

Copyright © 2022 Société Nationale Française de Médecine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved..

Acute Parvovirus B19 (PVB19) infection is responsible for erythema infectiosum in children and non-specific polyarthralgias in immunocompetent adults associated with skin lesions and rarer manifestations (hepatic, neurological, cardiac or nephrological). In immunocompromised patients, cytopenias are more frequent and in some cases, viremia persists and is responsible for PVB19 chronic infection. PVB19 is responsible for pure red cell aplasia during chronic hemolytic diseases. Acute PVB19 infection is a differential diagnosis of some autoimmune diseases and has been suspected to be a trigger for some autoimmune diseases because of its ability to promote the emergence of autoimmune markers. Mechanisms of molecular mimicry, induction of apoptosis and activation of enzymes have been demonstrated, explaining in part the production of autoantibodies during infection. However, the demonstration of a causal relationship in the triggering of autoimmune disease remains to be done. This review provides a synthesis of the PVB19 infection clinical data in adults with a particular focus on these links with autoimmunity.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:43

Enthalten in:

La Revue de medecine interne - 43(2022), 12 vom: 06. Dez., Seite 713-726

Sprache:

Französisch

Weiterer Titel:

Infection de l’adulte à Parvovirus

Beteiligte Personen:

Jacquot, R [VerfasserIn]
Gerfaud-Valentin, M [VerfasserIn]
Mekki, Y [VerfasserIn]
Billaud, G [VerfasserIn]
Jamilloux, Y [VerfasserIn]
Sève, P [VerfasserIn]

Links:

Volltext

Themen:

Antiphospholipid syndrome
Autoantibodies
English Abstract
Journal Article
Lupus
Parvovirus B19
Polyarthrite rhumatoïde
Review
Rheumatoid arthritis
SAPL
Systemic lupus erythematosus
Vascularites
Vasculitis

Anmerkungen:

Date Completed 06.12.2022

Date Revised 06.12.2022

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.revmed.2022.08.005

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM346051916